| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/20/2006 | US7064147 Amino acids with affinity for the α-2-delta-protein |
| 06/20/2006 | US7064136 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents |
| 06/20/2006 | US7064134 4-piperidinyl-substituted, e.g., 4-(2-methyl-4-piperidin-1-yl-quinolin-7-ylmethoxy)-benzonitrile; treating eating disorders and obesity |
| 06/20/2006 | US7064123 substituted acetamides; uses for treating diseases including arthritis, muscular dystrophy, inflammation, tumor invasion, glomerulonephritis, malaria, periodontal disease, and metachromatic leukodystrophy |
| 06/20/2006 | US7064122 Pancreatic lipase inhibitor compounds, their synthesis and use |
| 06/20/2006 | US7064115 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 06/20/2006 | US7064106 Protein, as a reagent for screening a compound that inhibit the binding of the protein to insulin responsive aminopeptidase or to glucose transporter 4; useful as a preventive/remedy for hyperglycemia and diabetes melliuts etc. |
| 06/20/2006 | US7063958 that encode a receptor for leptin, including a naturally occurring soluble form of the receptor that is expected to modulate, especially agonize, leptin activity; could be used to treat obesity |
| 06/20/2006 | US7063865 Mixture of glycine, glutathione, vitamins and minerals; hangover therapy |
| 06/20/2006 | US7063861 Bioavailable composition of natural and synthetic HCA |
| 06/20/2006 | CA2379633C Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines |
| 06/20/2006 | CA2379585C Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines |
| 06/20/2006 | CA2162706C 1-arylcycloalkyl sulphides, sulphoxides and sulphones for the treatment of depression, anxiety and parkinson's disease |
| 06/20/2006 | CA2121523C Sulfonamide derivatives |
| 06/15/2006 | WO2006062481A1 New benzofuran derivatives and their use in the treatment of obesity, type ii diabetes and cns disorders . |
| 06/15/2006 | WO2006062224A1 Carboxamide derivative |
| 06/15/2006 | WO2006062104A1 Bacillus macroides strain and food using the same |
| 06/15/2006 | WO2006062063A1 Piperidine derivative and process for producing the same |
| 06/15/2006 | WO2006061992A1 Preventive/therapeutic composition for liver disease |
| 06/15/2006 | WO2006061140A2 Composition of ssao substrates and metal compounds of the vla and vlb groups of the periodic table |
| 06/15/2006 | WO2006060951A1 A pharmaceutical composition for the treatment and/or prevention of hyperlipidemia, processes for producing the same and the use thereof |
| 06/15/2006 | WO2006060920A1 Novel uses of egf |
| 06/15/2006 | WO2006050999A3 Methods of reducing body fat |
| 06/15/2006 | WO2006044573A3 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
| 06/15/2006 | WO2006010775A8 Tyrosine derivatives as ppar-gamma-modulators |
| 06/15/2006 | WO2005089786A3 Y4 selective receptor agonists for therapeutic interventions |
| 06/15/2006 | WO2001082928A9 Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism |
| 06/15/2006 | US20060130164 Toll/interleukin-1 receptor adapter protein (TIRAP) |
| 06/15/2006 | US20060128973 N-[4-[(1E)-3-amino-1-propenyl]phenyl]-4'-(trifluoromethyl)-[1,1'-biphenyl]-2-carboxamide; for treatment of hyperlipidemia, obesity and type II diabetes |
| 06/15/2006 | US20060128972 N-(p-(2-alpha-carboxybenzylamino)ethylamino)phenyl)p-(p-trifluoromethylphenyl)benzamide; antiobesity and anti-type II diabetic agents |
| 06/15/2006 | US20060128807 Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof |
| 06/15/2006 | US20060128787 Acyl-CoA: cholesterol acyltransferase and lipoxygenase inhibitors; superior oral absorbability; strong antihyperlipidemia effect and an anti-arteriosclerosis effect; N-(5-methanesulfonylamino-4,6-dimethyl-1-propylindolin-7-yl)-2,2-dimethylpropanamide |
| 06/15/2006 | US20060128784 Bis-heteroaryl alkanes as therapeutic agents |
| 06/15/2006 | US20060128776 Opioid receptor active compounds |
| 06/15/2006 | US20060128772 2-(2-methoxyphenyl)-3-(2-methoxy-phenyl)-5-phenylamino-(1,2,4)-thiadiazol-2 -ium; metabolic, nervous system and dermatological disorders, antidiabetic; obesity, impaired oral glucose tolerance, type II diabetes and Syndrome X, acne, dry skin and seborrheic dermatitis |
| 06/15/2006 | US20060128755 3'-trifluoromethyl-3,4,5,6-tetrahydro-2H-[1,2']-bipyridinyl-4-carboxylic acid (4-isopropylphenyl)amide; antiinflammatory and analgesic |
| 06/15/2006 | US20060128751 CETP inhibitors in combination with antihypertensive agents and uses thereof |
| 06/15/2006 | US20060128745 Chemical compounds |
| 06/15/2006 | US20060128705 Method of treating chronic fatigue syndrome |
| 06/15/2006 | US20060128701 N-{4-[ethyl-(2-hydroxy-ethyl)-amino]-phenyl}-2-[4-(2-oxo-4H-benzo[d][1,3]oxazin-1- yl)-piperidin-1-yl]-acetamide; Eating disorders; CNS disorders; antidiabetic agents; psychological disorders; antiepileptic, antiinflammatory agents, autoimmune diseases; neuropeptide Y5 (NPY5) receptor antagonists |
| 06/15/2006 | US20060128695 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 06/15/2006 | US20060128664 Aryl boronic acids for treating obesity |
| 06/15/2006 | US20060128663 Aryl boronate functionalized polymers for treating obesity |
| 06/15/2006 | US20060128662 Novel compounds for treatment of obesity |
| 06/15/2006 | US20060128656 Charged phospholipid compositions and methods for their use |
| 06/15/2006 | US20060128635 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
| 06/15/2006 | US20060128629 Angiogenesis inhibitors, antitumor agents |
| 06/15/2006 | US20060128626 Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes |
| 06/15/2006 | US20060128606 Fibrils |
| 06/15/2006 | US20060128003 Therapeutic agents for low HDL-cholesterolemia |
| 06/15/2006 | US20060127873 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors |
| 06/15/2006 | US20060127499 Vitamin-mineral compositions |
| 06/15/2006 | US20060127475 tablet comprising disintegrant such as carmellose, sodium carboxymethyl starch, croscarmellose sodium, crospovidone, partly pregelatinized starch and low-substituted hydroxypropyl cellulose |
| 06/15/2006 | US20060127464 Female hormone-containing patch |
| 06/15/2006 | US20060127411 Immune -modulating peptide made of s.aureus enterotoxin b |
| 06/15/2006 | US20060127378 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 06/15/2006 | US20060127362 Cholesterol-Lowering preparation, food supplement and foodstuff, and methods for preparing same |
| 06/15/2006 | US20060127353 Fat-binding polymers |
| 06/15/2006 | CA2638753A1 Methods, assays and compositions for treating retinol-related diseases |
| 06/15/2006 | CA2590500A1 Use of egf to treat or prevent pathogenic infections and to promote weight gain |
| 06/15/2006 | CA2587749A1 Piperidine derivative and process for producing the same |
| 06/14/2006 | EP1669462A1 Method of preparing alpha-glycosylisoquercitrin, intermediate therefor and by-product |
| 06/14/2006 | EP1669350A1 Novel piperidine derivative |
| 06/14/2006 | EP1669345A1 Ester derivative and medicinal use thereof |
| 06/14/2006 | EP1669088A1 METHOD OF TREATING DIABETES BY INHIBTING DEGRADATION OF AT LEAST ONE OF CREBL1, ATF6 and HNF-4 ALPHA BY HtrA2 |
| 06/14/2006 | EP1669081A1 Apoptotic entities for use in treatment of T-cell-mediated und inflammatory disorders |
| 06/14/2006 | EP1669079A1 Composition of SSAO substrates and metal compounds of the Vla Vlb groups of the periodic table |
| 06/14/2006 | EP1669069A1 Compounds effecting glukokinase |
| 06/14/2006 | EP1669068A1 Compounds effecting Glucokinase |
| 06/14/2006 | EP1669067A2 Flavonoids for cystic fibrosis therapy |
| 06/14/2006 | EP1668004A1 Benzoxazole acetonitriles |
| 06/14/2006 | EP1667997A1 Pyrimidine and pyridine derivatives useful as hmg-coa reductase inhibitors and method of preparation thereof |
| 06/14/2006 | EP1667970A1 Heterocyclic- or aryloxy, -thio 0r -amino substituted indoles-2-carboxylic acids or esters as pai-1 inhibitors |
| 06/14/2006 | EP1667969A1 Substituted sulfonamide-indole-2-carboxylic acid derivatives as pai-1 inhibitors |
| 06/14/2006 | EP1667770A2 Novel derivatives of 4a,5,9,10,11,12-hexahydrobenzofuro [3a,3,2][ 2]- benzazepine, method for the production thereof and use thereof in the production of medicaments |
| 06/14/2006 | EP1667769A2 Use of galanthamine and the derivatives thereof in the production of medicaments |
| 06/14/2006 | EP1667721A2 Combinations of a vegf receptor inhibitor with other therapeutic agents |
| 06/14/2006 | EP1667692A1 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an estrogen agonist/antagonist |
| 06/14/2006 | EP1667691A1 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a bisphosphonate |
| 06/14/2006 | EP1667690A1 2-alkylidene-19-nor-vitamin d derivatives for the treatment of osteopenia or male osteoporosis |
| 06/14/2006 | EP1667689A1 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone |
| 06/14/2006 | EP1667688A1 2-alkylidene-19-nor-vitamin d derivatives for the treatment of frailty, muscle damage or sarcopenia |
| 06/14/2006 | EP1667679A1 Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 06/14/2006 | EP1667673A1 Alpha-linolenic acid and alpha-linolenic acid-containing vegetable oils used for combating diabetes |
| 06/14/2006 | EP1667524A2 Novel crystalline form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 06/14/2006 | EP1496884B1 Association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases |
| 06/14/2006 | EP1476434B1 Pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same |
| 06/14/2006 | EP1446404B1 Rosiglitazone edisylates and their use as antidiabetics |
| 06/14/2006 | EP1399439B1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 06/14/2006 | EP1381373B1 Medical compositions for use in the treatment or prevention of a functional vitamin b12 deficienfcy |
| 06/14/2006 | EP1341770B1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors |
| 06/14/2006 | EP1341759B1 3-substituted oxindole beta 3 agonists |
| 06/14/2006 | EP1339683B1 Estrogen receptor modulators |
| 06/14/2006 | EP1335701B1 Anti-adiposis topical treatment composition based on garlic bulb extracts |
| 06/14/2006 | EP1309564B1 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists |
| 06/14/2006 | EP1214324B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/14/2006 | EP1175205B1 Solid dispersion comprising ritonavir, fenofibrate or griseofulvin |
| 06/14/2006 | EP1165085B1 Phthalazine derivatives for treating inflammatory diseases |
| 06/14/2006 | EP1135115B1 Use of sibutramine for the treatment of disorders of the central nervous system secondary to organic impairments |
| 06/14/2006 | EP1071439B1 Rose-hip formulations as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and arthritis |